<DOC>
	<DOCNO>NCT02761005</DOCNO>
	<brief_summary>Patients infect H. pylorus treat individualized regimen base mutation 23S rRNA H. pylorus .</brief_summary>
	<brief_title>Eradication H. Pylori Therapy Individualized Mutation 23S rRNA H. Pylori</brief_title>
	<detailed_description>Patients infect H. pylorus undergo gastroscopy . During gastroscopy , gastric mucus sample collect , DNA extract . The DNA sample subject full-auto SNP analyzer A G mutation 23 rRNA H. pylorus position 2142 2143 measure . When mutation detect , patient diagnose infected clarithromycin-resistant strain H. pylorus therefore , treat triple therapy vonoprazan 20 mg bid + amoxicillin 750 mg bid + metronidazole 250 mg bid 1 week . When mutation detect , patient consider infected clarithromycin-sensitive strain H. pylorus therefore , treat triple therapy vonoprazan 20 mg bid + amoxicillin 750 mg bid + clarithromycin 200 mg bid 1 week . The success failure eradication determine base 13C-urea breath test perform 1 month therapy . The total eradication rate strategy compare standard regimen Japan perform period study .</detailed_description>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Patients infect H. pylorus invite study . Patients allergic drug use eradication H. pylorus . Patients agree participate study . Patients allergic drug use eradication H. pylorus . Patients agree study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Eradication therapy</keyword>
	<keyword>Mutation 23S rRNA H. pylorus</keyword>
	<keyword>Personalized therapy</keyword>
</DOC>